SCHEMBL564204

SCHEMBL564204

CC(C)CN(Cc1cc(Cl)c2c(c1)OCCCO2)C(=O)C(C)CN(C)c1cccc2c1OCCO2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.56
MAPK8 P45983 1/20 0.35
HTT P42858 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MTNR1A P48039 3/20 0.31
CTNNB1 P35222 3/20 0.31
WNT3A P56704 3/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
MAP3K7 O43318 1/20 0.30
TAB1 Q15750 1/20 0.30
BRD4 O60885 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565620 0.97 PROKR2 (0.55) PROKR2MAPK8HTTALDH1A1MTNR1A
SCHEMBL565182 0.91 PROKR2 (0.54) PROKR2MAPK8HTTALDH1A1
SCHEMBL565585 0.88 PROKR2 (0.52) PROKR2MAPK8
SCHEMBL564804 0.87 PROKR2 (0.55) PROKR2MAPK8
SCHEMBL565094 0.87 PROKR2 (0.58) PROKR2MAPK8NPC1RAB9A
SCHEMBL565849 0.87 PROKR2 (0.51) PROKR2MAPK8HTT
SCHEMBL565604 0.87 PROKR2 (0.58) PROKR2MAPK8NPC1RAB9A
SCHEMBL565686 0.87 PROKR2 (0.53) PROKR2MAPK8HTT
SCHEMBL565625 0.87 PROKR2 (0.55) PROKR2MAPK8
SCHEMBL565576 0.87 PROKR2 (0.55) PROKR2MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885MAPK8 1270/4885HTT 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.